Abbott Laboratories vs. PERRIGO COMPANY PLC
Abbott Laboratories (ABT) comes out ahead, leading on 6 of 9 compared factors.
Size & Scale
| ABT | PRGO | |
|---|---|---|
| Market Cap | $177.55 billion | $1.88 billion |
| Revenue (TTM) | $46.59 billion | $4.14 billion |
| Net Income (TTM) | $5.42 billion | $-1,734,800,000 |
ABT leads on 3 of 3 size & scale factors.
Valuation
| ABT | PRGO | |
|---|---|---|
| P/E Ratio | 33.33 | — |
| Price / Book | 3.43 | 0.75 |
| Price / Sales | 3.81 | 0.45 |
PRGO leads on 2 of 2 valuation factors.
Profitability
| ABT | PRGO | |
|---|---|---|
| Net Margin | 11.65% | -41.85% |
| Return on Equity | 10.48% | -68.96% |
ABT leads on 2 of 2 profitability factors.
Dividend
| ABT | PRGO | |
|---|---|---|
| Dividend Yield | 2.45% | 8.55% |
| Payout Ratio | 81.55 | — |
PRGO leads on 1 of 1 dividend factors.
Risk & Sentiment
| ABT | PRGO | |
|---|---|---|
| Short Interest | 0.57% | 2.42% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, PRGO overview, PRGO financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.